Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

US Patent 11234994 · Granted Feb 1, 2022

Estimated economic value: $1,026,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Collapsible work stand with adjustable platforms2025
Methods and compositions for synthetic biomarkers2025
Methods and compositions for synthetic biomarkers2024
Treatment of muscular dystrophies2024
Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use ther2024
Oligomers2023
Neurodegenerative disorders2023
Tunable dynamic absorber for attenuating vibration2023
Reagents for treatment of hepatitis B virus (HBV) infection and use thereof2022
Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use ther2021
Oligomers2021
Reagents for treatment of hepatitis B virus (HBV) infection and use thereof2021